IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#331
Positioning
Market Dominance
Services
Healthcare
$13.0B
Marc D. Miller
Universal Health Services, Inc. owns and operates acute care hospitals, and outpatient and behavioral health care facilities. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services.
Headcount
93.8K
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = UHS ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | 21.3% | 18.6% | 64.5% | 35.7% | 39.5% | 6.5% | 0.0% | 0.0x | $644M | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | 15.4% | 12.6% | 38.7% | 17.1% | 17.0% | -39.7% | 0.0% | 0.0x | $439M | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 28.1% | 16.8% | 48.1% | 23.8% | 18.5% | 78.6% | 0.0% | 37.0x | $220M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | 12.4% | 2.9% | 100.0% | 28.2% | 26.2% | 5.5% | 0.8% | 264.0x | $19.4B | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.6% | 7.8% | 43.8% | 7.4% | 5.9% | 31.2% | 0.0% | 0.0x | $857M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 18.0% | 4.6% | 97.3% | 52.2% | 32.7% | -3.4% | 0.0% | 271.0x | $8.0B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | 9.4% | 4.9% | 55.5% | 8.7% | 7.7% | 13.6% | 1.3% | 7.0x | $78.0B | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | 22.1% | 15.6% | 62.5% | 28.1% | 28.7% | -1.0% | 2.8% | 9.0x | $56.6B | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 21.4% | 8.0% | 100.0% | 10.0% | 7.5% | 14.1% | 0.0% | 27.0x | $1.8B | VS | |
$UHS UNIVERSAL HEALTH SERVICES INC | 64 | 62 | 74 | 76 | 10.8x | 7.8x | 18.4% | 8.7% | 54.0% | 11.0% | 7.9% | 15.0% | 0.4% | 65.0x | $13.0B | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.3% | 1.9% | 59.6% | 3.5% | 2.3% | 7.8% | 0.0% | 0.3x | - | REF |
UNIVERSAL HEALTH SERVICES INC (UHS) receives a "Hold" rating with a composite score of 64.3/100. It ranks #331 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
No analyst ratings for UHS.
View All RatingsVerified SEC Filings Aggregate
Access the primary source of truth. Direct unfiltered access to 10-K, 10-Q and 8-K filings for UHS.
Open Regulatory DossierFigures adjusted for stock splits and restatements where applicable.
TTM (Trailing Twelve Months) data updates within 48 hours of quarterly filings.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Marc D. Miller
Chief Executive Officer
Labor Force
93,800
62
35
82
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for UHS
HQ Base
King of Prussia, Pennsylvania
Outperforming peers — winners tend to keep winning over 3-12 months
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 62 | 77 | -15DRAG |
| MOMENTUM | 76 | 85 | -9DRAG |
| VALUATION | 74 | 83 | -9DRAG |
| INVESTMENT | 35 | 56 | -21DRAG |
| STABILITY | 82 | 90 | -8DRAG |
| SHORT INT | 53 | 62 | -9DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 8.6% vs WACC 7.5% (spread +1.1%)
GM 54% vs sector 60%, OM 11% vs sector 4%
Capital turnover 0.98x
Rev growth 15%, 10yr history
Interest coverage 13.6x, Net debt/EBITDA 6.8x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns UNIVERSAL HEALTH SERVICES INC a Hold rating, with a composite score of 64.3/100 and 3 out of 5 stars. Ranked #331 of 7,333 stocks, UHS presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 62/100, UHS shows adequate but unremarkable business quality. The company reports a return on equity of 18.4% (sector avg: 5.3%), gross margins of 54.0% (sector avg: 59.6%), net margins of 7.9% (sector avg: 2.3%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
UHS carries a solid value score of 74/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 10.83x, an EV/EBITDA of 7.75x, a P/B ratio of 1.99x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
UNIVERSAL HEALTH SERVICES INC's investment score of 35/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 15.0% vs. a sector average of 7.8% and a return on assets of 8.7% (sector: 1.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
UHS shows strong momentum characteristics with a score of 76/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at 15.0% year-over-year, while a beta of 0.62 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
UHS shows good financial stability with a score of 82/100. Key stability metrics include a beta of 0.62 and a debt-to-equity ratio of 65.00x (sector avg: 0.3x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
The short interest score of 53/100 for UHS suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 65.00x). With a $13.0B market cap (large-cap), UNIVERSAL HEALTH SERVICES INC may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
UHS offers a modest dividend yield of 0.4%. While the income contribution is relatively small, even a small dividend signals management's commitment to shareholder returns and can serve as a signal of financial discipline.
UNIVERSAL HEALTH SERVICES INC is a large-cap company in the Services sector, ranked #41 of 50 in its sector (18th percentile) and #331 of 7,333 overall (95th percentile). Key comparisons include ROE of 18.4% exceeding the 5.3% sector median and operating margins of 11.0% above the 3.5% sector average. This bottom-quartile standing highlights significant competitive headwinds within the Services space.
While UHS currently exhibits a HOLD profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Key factor gap
Stability (82) vs Investment (35) — closing this gap could shift the rating.
RANK #41 OF 50 IN CONSUMER DISCRETIONARY
EV/EBITDA 34% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 246% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 9% BELOW SECTOR MEDIAN
Relative to Services Median (N=802)
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Dates updated upon official exchange announcement.
Neutral
Bullish Accumulation
Low
Institutional cap table data requires verified 13F filing feeds.
Access SEC 13F Dossier →Insider transaction data currently awaiting regulatory verification.
Access SEC Form 4 Dossier →Smart Money conviction levels above 70 indicate significant institutional accumulation.
Data aggregates 13F and Form 4 filings with a 24-hour verification delay.
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate UNIVERSAL HEALTH SERVICES INC (UHS) as a Hold with a composite score of 64.3/100 at a current price of $229.96. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in stability (82th percentile) and momentum (76th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (35th percentile) and quality (62th percentile) tempers our overall conviction. We assign a Narrow Moat rating (45/100), Low uncertainty, and Standard capital allocation.
Key items to watch: quarterly earnings execution and sector-level competitive dynamics. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
UNIVERSAL HEALTH SERVICES INC holds a lower-quartile position (#41 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 64.3/100 places it at rank #331 in our full 7,333-stock universe. With a $13.0B market capitalization, UNIVERSAL HEALTH SERVICES INC operates at meaningful scale within the Services sector, providing competitive advantages in distribution, procurement, and customer reach.
The near-term outlook is constructive, with revenue growing at 15% and momentum in the 76th percentile confirming positive market sentiment and institutional accumulation. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy. Investment factor at the 35th percentile indicates reinvestment patterns that investors should monitor for sustainability.
The margin cascade tells an important story: gross margins of 54% (-5.6pp vs sector) narrow to operating margins of 11% (+7.5pp vs sector) and net margins of 7.9%, yielding a gross-to-net conversion rate of 15%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
We assign UNIVERSAL HEALTH SERVICES INC a Narrow Moat rating with a composite moat score of 45/100. The ROIC-WACC spread of +1.1% is the primary signal of economic value creation. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that UNIVERSAL HEALTH SERVICES INC can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being margin superiority at 13.1/20.
The strongest moat sources are margin superiority (13.1/20) and financial resilience (12.2/20). GM 54% vs sector 60%, OM 11% vs sector 4%. Interest coverage 13.6x, Net debt/EBITDA 6.8x. These pillars form the core of UNIVERSAL HEALTH SERVICES INC's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (1.9/20) and economic value creation (6/20). Capital turnover 0.98x. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect UNIVERSAL HEALTH SERVICES INC's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
At a current price of $229.96, UNIVERSAL HEALTH SERVICES INC appears undervalued relative to its fundamentals. Our value factor score of 74/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at a P/E of 10.8x (a 54% discount to the sector median of 23.7x), EV/EBITDA of 7.8x (discounted to peers), P/B of 2.0x, P/S of 0.9x. The below-sector P/E suggests possible undervaluation or the market pricing in near-term headwinds.
Key profit drivers include gross margins of 54% providing a solid profitability foundation, operating margins of 11% reflecting effective cost management, robust top-line growth of 15% expanding the revenue base. The margin cascade from 54% gross to 11% operating to 7.9% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 62th percentile.
The margin profile shows gross margins of 54%, operating margins of 11%, net margins of 7.9%. Return metrics include ROE of 18.4% and ROA of 8.7%. Relative to the Services sector, gross margins are 5.6 percentage points below the sector median of 60%, and ROE of 18.4% compares to a sector median of 5.3%.
The balance sheet reflects moderate leverage with D/E of 65%, a dividend yield of 0.39%, revenue growth of 15%. The sector median D/E is 0%, putting UNIVERSAL HEALTH SERVICES INC at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Gross margins of 54% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Returns on equity of 18.4% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
Revenue growth of 15% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
A value factor score of 74/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Positive momentum (76th percentile) indicates institutional accumulation and favorable technical dynamics that tend to persist in the intermediate term.
Even high-quality stocks face risks from valuation compression, competitive disruption, or macro shocks that are difficult to quantify in advance.
We assign a Low uncertainty rating to UNIVERSAL HEALTH SERVICES INC. The company exhibits strong financial stability with a beta of 0.62, and a stability factor in the 82th percentile. The predictable nature of the business model and solid financial position reduce the range of potential outcomes, giving us confidence in our fair value estimate.
Specific risk factors that inform our assessment include: low beta of 0.62 — while defensive, this may indicate limited upside participation in bull markets. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 82th percentile and quality factor at the 62th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 54% provide a buffer against cost pressures; above-average stability (82th percentile) suggests predictable business dynamics. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate UNIVERSAL HEALTH SERVICES INC's capital allocation as Standard. Management has shown adequate — though not exceptional — stewardship of shareholder capital. Returns on equity stand at 18.4%, and the balance sheet is managed within acceptable parameters (D/E: 65%). Exemplary allocators typically sustain ROE above 20% and D/E below 50%; UNIVERSAL HEALTH SERVICES INC falls short on at least one dimension.
There is room for improvement in optimizing the capital structure or enhancing shareholder returns. The 0.39% dividend yield provides some income return, but the overall capital allocation framework would benefit from either higher reinvestment returns, improved balance sheet efficiency, or increased shareholder distributions. We will monitor for signs of strategic improvement that could warrant an upgrade.
In summary, UNIVERSAL HEALTH SERVICES INC receives a Hold rating with a composite score of 64.3/100 (rank #331 of 7,333). Our quantitative framework assigns a Narrow Moat (45/100, trend: stable), Low uncertainty, and Standard capital allocation. The average factor score across quality, value, momentum, stability, and investment is 66/100.
Our analysis supports a neutral stance on UNIVERSAL HEALTH SERVICES INC. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Above 50MA
37.18%
Net New Highs
+51081
Universal Health Services (NYSE:UHS) reported quarterly earnings that surpassed Wall Street expectations. Results were supported by a recent Medicaid reimbursement and steady demand across its facilities. Management raised its revenue outlook for 2025 following the reimbursement and stronger operating trends. For investors watching NYSE:UHS, the latest update comes with the stock trading around $230.49 and a 1 year return of 28.6%. Over 3 years the stock has returned 59.1%, and over 5 years...

The article highlights three healthcare stocks trading at attractive valuations: DaVita, Merck, and Universal Health Services, which offer potential investment opportunities despite current market challenges.

Universal Health Realty Income Trust reported a slight decline in net income and funds from operations in Q2 2025, with minor revenue growth and a cautious dividend increase amid challenging healthcare operating environment.

Universal Health Services has had an impressive run over the past six months as its shares have beaten the S&P 500 by 26%. The stock now trades at $234.41, marking a 32% gain. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Investors will assess the Supreme Court's tariff decision and look ahead to Nvidia's latest financial results.